2Department of Radiology, Medipol University Faculty of Medicine, Istanbul
3Department of Pediatrics, Division of Hematology and Oncology, Selcuk University Faculty of Medicine, Konya OBJECTIVES
The purpose of this retrospective study is to share the data of the patients with high alpha-fetoprotein and benign/borderline liver mass with literature.
METHODS
Between 2006 and 2012, 5 of our patients were diagnosed with
benign/borderline liver mass in connection with high alphafetoprotein.
RESULTS
During the diagnostic procedure, alpha-fetoprotein values of
our patients were varying between 123-4905 U/L. While one
of the patients diagnosed with hemangioendothelioma was
transferred for liver transplantation, the other passed away during
the early stages under steroid treatment. After observing
malign cells in tissue biopsy, chemotherapy was started for
the patient diagnosed with mesenchymal hamartoma and the
mass was removed completely. It is currently being monitored
and is free of any diseases. Patients, who were diagnosed with
hemangioma and focal nodular hyperplasia, were monitored
without receiving any treatment.
CONCLUSION
Since it is possible to observe high alpha-fetoprotein in nonmalign
liver masses, tissue diagnosis must be confirmed before
starting treatment.